CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
The effect of febuxostat to prevent a further reduction in renal function of patients with hyperuricemia who have never had gout and are complicated by chronic kidney disease stage 3: study protocol for a multicenter randomized controlled study
Authors
A Kottgen
A Whelton
+61 more
AS Go
BA Grabowski
BO Eriksen
CA Sarawate
DE Weiner
DH Kang
DS Keith
E Imai
EM Damsgaard
F Irie
H Yamanaka
Hirofumi Makino
Hiroshi Hayakawa
HR Schumacher Jr
HR Schumacher Jr
I Garcia-Valladares
Iwao Ohno
J Nogueira
Japan Nephrology Society
K Iseki
K Iseki
K Okamoto
Kenjiro Kimura
LG Sánchez-Lozada
LG Sánchez-Lozada
LS Dalrymple
M Chonchol
M Goicoechea
M Mazzali
M Mazzali
MA Becker
MA Becker
MA Becker
Masaaki Inaba
Masanari Kuwabara
MD Mayer
N Dalbeth
N Kamatani
N Kamatani
Naohiko Imai
R Terkeltaub
S Hoshide
S Hoshide
S Uchida
Sadayoshi Itoh
Satoshi Iimuro
Seiichi Matsuo
Shunya Uchida
T Neogi
T Ninomiya
T Spector
T Yamamoto
Tatsuo Hosoya
Tetsuya Yamamoto
V Massey
WB Kannel
WM Mikkelsen
Y Takano
Yasuhiko Tomino
YP Siu
Yugo Shibagaki
Publication date
Publisher
'Springer Science and Business Media LLC'
Doi
Cite
Abstract
Abstract is not available.
Similar works
Full text
Open in the Core reader
Download PDF
Available Versions
Crossref
See this paper in CORE
Go to the repository landing page
Download from data provider
info:doi/10.1186%2F1745-6215-1...
Last time updated on 01/04/2019